CABA compared with STTK: revenue, margins and what each company keeps, and the suppliers and customers both name

CABACabaletta Bio, Inc.

Mkt capRevenueRevenue

STTKShattuck Labs, Inc.

Mkt capRevenueRevenue

Compare

CABACabaletta Bio, Inc.

STTKShattuck Labs, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

rebased to 0%

CABA, solidSTTK, dashed

Supply-chain overlap

Revenue flow

CABA: latest quarter not drawable. STTK: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only CABA 14

—Autolus Holdings (UK) Limited (Autolus)unlistedsupplier

—Carotunlistedsupplier

—Cellaresunlistedsupplier

—Children's Hospital of Philadelphiaunlistedsupplier

10 more · CABA chain ›

Shared 0

No shared counterparties.

Only STTK 4

—Kemwell Biopharma Privateunlistedsupplier

—ImmunoGenunlistedcustomer

—Kayak Therapeuticsunlistedcustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

—Ono Pharmaceuticalunlistedcustomer

CABACabaletta Bio, Inc.

1.51▼−4.73%· post 1.50

Mkt cap$256.0MRevenue—

STTKShattuck Labs, Inc.

5.54▼−3.18%· post 5.54

ClosedOct 30 '26

Mkt cap$558.0MRevenue$1MQ3 FY25

Compare

ClosedOct 30 '26

CABACabaletta Bio, Inc.

STTKShattuck Labs, Inc.

1.51▼−4.73%post 1.50

Price

5.54▼−3.18%post 5.54

$256.0M

Mkt cap

$558.0M

—

Revenue

$1MQ3 FY25

CABA1.51▼−4.73%vsSTTK5.54▼−3.18%ClosedOct 30 '26